Trial intelligence / Profile preview

MMSCs for Knee Osteoarthritis

NCT04453111Phase 2Unknown

Sponsor
Institute of Cell Therapy
Start
Jan 2020
Primary completion
Aug 2021
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of placenta-derived mesenchymal stem cells, bone marrow-derived mesenchymal stem cells in knee osteoarthritis (OA), sponsored by Institute of Cell Therapy. Status: unknown.

02

Drugs

placenta-derived mesenchymal stem cellsbone marrow-derived mesenchymal stem cells
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT04453111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04453111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call